Literature DB >> 25728049

Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.

H-Q Du1, X Zhang1, Y-F An1,2, Y Ding1,2, X-D Zhao1,2.   

Abstract

The Wiskott-Aldrich syndrome protein (WASp) is an important regulator of the actin cytoskeleton and is required for immune cell function. WASp deficiency causes a marked reduction in major mature peripheral B cell subsets, particularly marginal zone (MZ) B cells. We hypothesized that WASp deficiency may also lead to a reduction of regulatory B cells (known as B10 cells) belonging to a novel subset of B cells. And in consideration of the key role of B10 cells play in maintaining peripheral tolerance, we conjectured that a deficit of these cells could contribute to the autoimmunity in patients with Wiskott-Aldrich syndrome (WAS). The effects of WASp deficiency on B10 cells have been reported by only one group, which used an antigen-induced arthritis model. To add more information, we measured the percentage of B10 cells, regulatory T cells (Tregs) and Th1 cells in WASp knockout (WASp KO) mice. We also measured the percentage of B10 cells in patients with WAS by flow cytometry. Importantly, we used the non-induced autoimmune WASp KO mouse model to investigate the association between B10 cell frequency and the Treg/Th1 balance. We found that the percentage of B10 cells was reduced in both mice (steady state and inflammatory state) and in humans and that the lower B10 population correlated with an imbalance in the Treg/Th1 ratio in old WASp KO mice with autoimmune colitis. These findings suggest that WASp plays a crucial role in B10 cell development and that WASp-deficient B10 cells may contribute to autoimmunity in WAS.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728049     DOI: 10.1111/sji.12282

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.

Authors:  Elena Crestani; Stefano Volpi; Fabio Candotti; Silvia Giliani; Lucia Dora Notarangelo; Julia Chu; Juan Carlos Aldave Becerra; David Buchbinder; Janet Chou; Raif S Geha; Maria Kanariou; Alejandra King; Cinzia Mazza; Daniele Moratto; Robert Sokolic; Elizabeth Garabedian; Fulvio Porta; Maria Caterina Putti; Rima H Wakim; Erdyni Tsitsikov; Sung-Yun Pai; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2015-09-26       Impact factor: 10.793

2.  The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity.

Authors:  Ioannis Kalampokis; Guglielmo M Venturi; Jonathan C Poe; Jeffrey A Dvergsten; John W Sleasman; Thomas F Tedder
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

3.  Treatment of primary immunodeficiency with allogeneic transplant and gene therapy.

Authors:  Sung-Yun Pai
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome.

Authors:  Karla E Cervantes-Luevano; Nicoletta Caronni; Maria C Castiello; Elena Fontana; Giulia M Piperno; Asma Naseem; Paolo Uva; Marita Bosticardo; Genni E Marcovecchio; Luigi D Notarangelo; Maria P Cicalese; Alessandro Aiuti; Anna Villa; Federica Benvenuti
Journal:  J Allergy Clin Immunol       Date:  2018-02-13       Impact factor: 10.793

5.  Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.

Authors:  Baohui Yang; Xiongjun Tan; Xiao Xiong; Daoqi Wu; Gaofu Zhang; Mo Wang; Shifang Dong; Wei Liu; Haiping Yang; Qiu Li
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

Review 6.  Immunosuppressive Mechanisms of Regulatory B Cells.

Authors:  Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

Review 7.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

8.  Age-Dependent Defects of Regulatory B Cells in Wiskott-Aldrich Syndrome Gene Knockout Mice.

Authors:  Tadafumi Yokoyama; Ayumi Yoshizaki; Karen L Simon; Martha R Kirby; Stacie M Anderson; Fabio Candotti
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.